ROS1 Gene Mutation Recruiting Phase 2 Trials for Entrectinib (DB11986)

IndicationStatusPhase
DBCOND0082893 (ROS1 Gene Mutation)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03994796Genetic Testing in Guiding Treatment for Patients With Brain MetastasesTreatment